vs
Side-by-side financial comparison of MEDALLION FINANCIAL CORP (MFIN) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $39.6M, roughly 1.8× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 17.3%, a 18.6% gap on every dollar of revenue. On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs -10.9%). Over the past eight quarters, MEDALLION FINANCIAL CORP's revenue compounded faster (15.0% CAGR vs -15.0%).
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
MFIN vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.6M | $39.6M |
| Net Profit | $12.2M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 29.3% | 32.5% |
| Net Margin | 17.3% | 35.9% |
| Revenue YoY | 25.4% | -10.9% |
| Net Profit YoY | 20.3% | 117.2% |
| EPS (diluted) | $0.50 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.6M | $39.6M | ||
| Q3 25 | $58.7M | $43.4M | ||
| Q2 25 | $62.6M | $43.4M | ||
| Q1 25 | $63.0M | $47.3M | ||
| Q4 24 | $56.3M | $44.4M | ||
| Q3 24 | $53.3M | $53.1M | ||
| Q2 24 | $51.0M | $53.1M | ||
| Q1 24 | $53.3M | $54.8M |
| Q4 25 | $12.2M | $14.2M | ||
| Q3 25 | $7.8M | $12.8M | ||
| Q2 25 | $11.1M | $2.5M | ||
| Q1 25 | $12.0M | $21.5M | ||
| Q4 24 | $10.1M | $6.5M | ||
| Q3 24 | $8.6M | $2.8M | ||
| Q2 24 | $7.1M | $18.5M | ||
| Q1 24 | $10.0M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 29.3% | 32.5% | ||
| Q3 25 | 33.2% | 36.6% | ||
| Q2 25 | 31.1% | 33.6% | ||
| Q1 25 | 32.1% | 51.1% | ||
| Q4 24 | 32.8% | 10.6% | ||
| Q3 24 | 26.6% | 26.1% | ||
| Q2 24 | 24.3% | 51.4% | ||
| Q1 24 | 33.6% | 44.6% |
| Q4 25 | 17.3% | 35.9% | ||
| Q3 25 | 13.2% | 29.6% | ||
| Q2 25 | 17.7% | 5.7% | ||
| Q1 25 | 19.1% | 45.4% | ||
| Q4 24 | 18.0% | 14.7% | ||
| Q3 24 | 16.1% | 5.3% | ||
| Q2 24 | 13.9% | 34.8% | ||
| Q1 24 | 18.8% | 34.2% |
| Q4 25 | $0.50 | $0.15 | ||
| Q3 25 | $0.32 | $0.12 | ||
| Q2 25 | $0.46 | $0.02 | ||
| Q1 25 | $0.50 | $0.21 | ||
| Q4 24 | $0.43 | $0.05 | ||
| Q3 24 | $0.37 | $0.03 | ||
| Q2 24 | $0.30 | $0.20 | ||
| Q1 24 | $0.42 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.3M | $164.1M |
| Total DebtLower is stronger | $216.0M | $42.8M |
| Stockholders' EquityBook value | $408.6M | $248.3M |
| Total Assets | $3.0B | $380.4M |
| Debt / EquityLower = less leverage | 0.53× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.3M | $164.1M | ||
| Q3 25 | $72.5M | $127.4M | ||
| Q2 25 | $110.4M | $152.7M | ||
| Q1 25 | $131.5M | $132.1M | ||
| Q4 24 | $98.2M | $125.0M | ||
| Q3 24 | $120.6M | $137.4M | ||
| Q2 24 | $87.7M | — | ||
| Q1 24 | $54.8M | — |
| Q4 25 | $216.0M | $42.8M | ||
| Q3 25 | $215.7M | $21.1M | ||
| Q2 25 | $199.9M | $7.1M | ||
| Q1 25 | $199.7M | $6.9M | ||
| Q4 24 | $232.2M | $6.6M | ||
| Q3 24 | $232.0M | $823.2K | ||
| Q2 24 | $230.8M | — | ||
| Q1 24 | $225.6M | — |
| Q4 25 | $408.6M | $248.3M | ||
| Q3 25 | $397.4M | $248.0M | ||
| Q2 25 | $389.9M | $244.6M | ||
| Q1 25 | $380.2M | $226.4M | ||
| Q4 24 | $370.2M | $195.1M | ||
| Q3 24 | $362.4M | $205.0M | ||
| Q2 24 | $354.0M | $8.8M | ||
| Q1 24 | $349.0M | $9.0M |
| Q4 25 | $3.0B | $380.4M | ||
| Q3 25 | $2.9B | $321.4M | ||
| Q2 25 | $2.9B | $315.3M | ||
| Q1 25 | $2.8B | $284.6M | ||
| Q4 24 | $2.9B | $266.1M | ||
| Q3 24 | $2.9B | $296.5M | ||
| Q2 24 | $2.8B | $19.5M | ||
| Q1 24 | $2.6B | $19.8M |
| Q4 25 | 0.53× | 0.17× | ||
| Q3 25 | 0.54× | 0.09× | ||
| Q2 25 | 0.51× | 0.03× | ||
| Q1 25 | 0.53× | 0.03× | ||
| Q4 24 | 0.63× | 0.03× | ||
| Q3 24 | 0.64× | 0.00× | ||
| Q2 24 | 0.65× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 10.35× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | $52.0M | ||
| Q3 25 | $67.0M | $-20.9M | ||
| Q2 25 | $-10.7M | $-8.3M | ||
| Q1 25 | $36.3M | $1.9M | ||
| Q4 24 | $108.7M | $-7.3M | ||
| Q3 24 | $24.6M | $5.0M | ||
| Q2 24 | $27.6M | $19.2M | ||
| Q1 24 | $32.3M | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | 10.35× | 3.66× | ||
| Q3 25 | 8.63× | -1.63× | ||
| Q2 25 | -0.97× | -3.39× | ||
| Q1 25 | 3.02× | 0.09× | ||
| Q4 24 | 10.72× | -1.12× | ||
| Q3 24 | 2.86× | 1.77× | ||
| Q2 24 | 3.89× | 1.04× | ||
| Q1 24 | 3.22× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MFIN
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
